Application of the Euro Clonality next‐generation sequencing‐based marker screening approach to detect immunoglobulin heavy chain rearrangements in mantle cell lymphoma patients: first data from the Fondazione Italiana Linfomi MCL0208 trial

Minimal residual disease (MRD) determined by classic polymerase chain reaction (PCR) methods is a powerful outcome predictor in mantle cell lymphoma (MCL). Nevertheless, some technical pitfalls can reduce the rate of of molecular markers. Therefore, we applied the EuroClonality‐NGS IGH (next‐generat...

Descripción completa

Detalles Bibliográficos
Autores principales: Genuardi, Elisa, Romano, Greta, Beccuti, Marco, Alessandria, Beatrice, Mannina, Donato, Califano, Catello, Rota Scalabrini, Delia, Cortelazzo, Sergio, Ladetto, Marco, Ferrero, Simone, Calogero, Raffaele A., Cordero, Francesca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Haematological malignancy – Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8515379/
https://www.ncbi.nlm.nih.gov/pubmed/34002365
http://dx.doi.org/10.1111/bjh.17519

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8515379/
https://www.ncbi.nlm.nih.gov/pubmed/34002365
http://dx.doi.org/10.1111/bjh.17519

Ejemplares similares